Vemurafenib Active Not Recruiting Phase 1 / 2 Trials for Melanoma Treatment

Active Not RecruitingTreatment1 / 2 IdentifierTitleDrugs
NCT01897116A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma
NCT01657591Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma
NCT01943422Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma